Two dicopper(II) complexes bridged by N-phenolato-N′-[2-(dimethylamino)ethyl]oxamide (H3pdmaeox) and end-capped with 2,2′-diamino-4,4′-bithiazole (dabt) and 2,2′-bipyridine (bpy), respectively, namely [Cu2(pdmaeox)Cl(CH3OH)(dabt)]·CH3OH (1) and [Cu2(pdmaeox)(bpy)(H2O)]-(pic)·H2O (2) (where pic− denotes the picrate anion) have been synthesized. Complex 1 was characterized by elemental analysis, molar conductivity measurements, IR and electronic spectral studies, and single-crystal X-ray diffraction. The crystal structure analyses reveal that the dissymmetric unit of complex 1 contains a neutral dicopper(II) complex moiety [Cu2(pdmaeox)Cl-(CH3OH)(dabt)], in which the cis-pdmaeox3− ligand bridges two copper(II) ions with the separation of 5.2238(19) Å. Through hydrogen bonding interactions, complex 1 molecules are assembled into 3D supramolecular structures. The structure and DNA-binding activities of complex 2 have been reported in our previous paper. However, its other properties were not studied. In order to gain some insight into the structure–activity relationship, the reactivities towards DNA and protein of the two dicopper(II) complexes are studied both theoretically and experimentally. The DNA docking study suggests that all the two dicopper(II) complexes can interact with DNA through the minor groove, and the binding affinity follows the order of 1 > 2, which is further validated by spectral titration, electrochemical techniques, and viscosity measurements. Bovine serum albumin (BSA) binding activity studies revealed that the two dicopper(II) complexes can strongly quench the intrinsic fluorescence of BSA through a static quenching mechanism with the ratio of the dicopper(II) complex to BSA being 1 : 1, and the most possible binding site is in the proximity of Trp134. The in vitro anticancer activities indicate that the two dicopper(II) complexes are active against the selected tumor cell lines, and the order of in vitro anticancer activities is consistent with the DNA-binding affinities. The influence of structural variation of the terminal ligands in the dicopper(II) complexes on DNA-binding modes and anticancer activities is preliminarily discussed.
With the objective to improve the physicochemical properties and optimize pharmacokinetic performances of acetazolamide (ACA), a new zwitterionic cocrystal of ACA with proline (PRO), namely, ACA-PRO, was synthesized and characterized. The single-crystal X-ray diffraction analysis revealed that the cocrystal has a component ratio of 1 : 1 and is dominated by a three dimensional hydrogen bonding supramolecular structure. The water solubility and permeability of ACA in the cocrystal were simultaneously enhanced compared with pure ACA in physiological pH environments. The in vivo pharmacokinetic evaluation indicated that the relative bioavailability of ACA from the cocrystal was enhanced by 2.68-fold. The present investigation not only provides an alternative approach for optimizing physicochemical and pharmacokinetic properties of BCS class-IV drugs without changing the molecular structures and intrinsic bioactivities, but also enriches the current understanding of the structures of zwitterionic cocrystals and their behaviors in vitro and in vivo.